Work

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer

Year: 2020

Type: article

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2020.06.007

Authors: Kyrollis Attalla, Adam M. Farkas, Harry Anastos, Francois Audenet, Matthew D. Galsky, Nina Bhardwaj, John P. Sfakianos

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: NK cell exhaustion in metastatic melanoma, Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

OpenAlex ID: W3041918822

FWCI: 0.722

Cites: 17

Cited by: 18

Related to: 10